NCT02193503 2023-09-28
MVX-ONCO-1 in Patients With Solid Tumor
Maxivax SA
Phase 1 Active not recruiting
Clinical Trials
8 trialsNCT02896049 2021-07-27
Celsius TCS Hyperthermia System PMCF Trial
Celsius42 GmbH
Withdrawn
NCT01851772 2021-01-12
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Xoft, Inc.
Phase NA Completed
NCT01357863 2018-09-14
(TYCO1)
GlaxoSmithKline
Terminated
NCT00171964 2017-06-01
Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions
Novartis
Phase 4 Completed
NCT01160094 2016-03-28
TYCO
Novartis
Completed
NCT00827177 2014-01-24
Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1 Completed
NCT00874042 2012-07-23
Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1 Completed